Rnatics
Pre-clinicalRNATICS GmbH, a spin-off of the Technical University of Munich, was awarded €2.7 million in funding by the Federal Ministry of Research, Technology and Space (BMFTR). The grant will support the clinical development of RCS-21, an inhaled RNA therapeutic candidate that is the first of its kind for treating inflammatory and fibrotic lung diseases.
About
RNATICS GmbH, a spin-off of the Technical University of Munich, was awarded €2.7 million in funding by the Federal Ministry of Research, Technology and Space (BMFTR). The grant will support the clinical development of RCS-21, an inhaled RNA therapeutic candidate that is the first of its kind for treating inflammatory and fibrotic lung diseases.
Funding History
1Total raised: $3.5M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile